Overview

A Pragmatic Approach to Lower Diabetes Risk After Gestational Diabetes

Status:
Not yet recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
This study is testing whether daily metformin for 1 year postpartum can reduce risk of diabetes in patients who had gestational diabetes. Typical care for prediabetes after gestational diabetes is counseling on diet and lifestyle. This study is researching whether management of diabetes prevention is more effective with the drug metformin. This study will be conducted at Tufts Medical Center.
Phase:
Phase 3
Details
Lead Sponsor:
Tufts Medical Center
Treatments:
Metformin